State of Medtech

283. Avoiding FDA Cybersecurity Rejections: A Medtech Playbook with Blue Goat Cyber


Listen Later

Episode breakdown:

00:00 – Why Cybersecurity is a New FDA Blocker

02:50 – Meet Blue Goat Cyber: Medtech-Only Cybersecurity

04:18 – FDA’s 2023 Final Guidance on Cybersecurity

07:00 – 68% of Devices Are Network Connected (Here’s the Risk)

09:45 – Why Retrofitting Security Fails

13:30 – FDA Risk Management: ISO 14971 vs TIR5717:10 – Secure Software Dev: IEC 62304 & Who Actually Follows It

20:08 – Is ISO 27001 Enough? What the FDA Actually Wants

25:53 – Most Common Deficiency: Insecure Design

30:30 – Blue Goat’s 5-Phase Submission Strategy

36:30 – Hidden Costs of Submitting Late (Cyber ROI)

40:00 – When to Engage Cyber Experts (and What Happens if You Don’t)

Don’t Let Cybersecurity Risks Delay Your Medical Device Premarket Approval. Check out BlueGoatCyber.com

Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.

Subscribe to our Youtube Channel

https://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfg

Subscribe to our LinkedIn Newsletter

https://www.stateofmedtechpodcast.com/

Follow The State of MedTech on

LinkedIn https://www.linkedin.com/company/thestateofmedtech

Instagram https://www.instagram.com/stateofmedtech/

TikTok https://www.tiktok.com/@stateofmedtech

X https://twitter.com/StateofMedTech

Facebook https://www.facebook.com/stateofmedtech/

Follow Omar M. Khateeb on

LinkedIn https://www.linkedin.com/in/okhateeb/

Instagram https://www.instagram.com/omar.m.khateeb/

TikTok https://www.tiktok.com/@omarkhateebofficial

X https://twitter.com/OmarMKhateeb

Facebook https://www.facebook.com/OmarMKhateeb/



This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.

...more
View all episodesView all episodes
Download on the App Store

State of MedtechBy State of Medtech